Ms. Atkinson joined Foundation Medicine in 2016 and currently serves as vice president, biopharma business development, and leads the biopharma business development organization. She has more than 14 years of business development and commercialization experience in the diagnostics and pharmaceutical industries, specializing in structuring complex partnerships, negotiating transactions, and partnering strategy.
In her prior role at Foundation Medicine, Ms. Atkinson served as senior director, corporate and business development, leading companion diagnostics (CDx) business development efforts. Prior to joining Foundation Medicine, Ms. Atkinson served as a member of the business development team at Asuragen where she was responsible for developing and executing pharmaceutical partnerships and collaborations. Prior to Asuragen, she served in a leadership role within the commercial organization of Merck & Co.
Ms. Atkinson earned her degree in Molecular Biology from The University of Texas at Austin.